Title for MeetingAbstracts
Alphabetical listing of titles
Zidovudine (AZT) treatment in AIDS and ARC.
Zidovudine (AZT) treatment of the AIDS dementia complex (ADC): results of a placebo-controlled, multicentered therapeutic trial.
Zidovudine (AZT) use after HIV exposure: a survey of US hospitals.
Zidovudine (AZT) use after occupational exposure to HIV-infected blood.
Zidovudine (AZT) use after occupational HIV exposure: toxicity and failures reported to CDC.
Zidovudine (AZT), preventive treatment of AIDS in HIV seropositive patients?
Zidovudine (ZDV) and interferon-alpha 2a (IFN): ongoing assessment of synergy and tolerance in early ARC patients, ACTG 068. The ACTG 068 Collaborative Group.
Zidovudine (ZDV) and whey protein concentrate (WPC) modulation fo Glutathione in Microglia.
Zidovudine (ZDV) disposition in semen and serum of HIV-infected men.
Zidovudine (ZDV) for perinatal prophylaxis starting on week 24 in Argentina.
Zidovudine (ZDV) for prophylaxis of perinatal transmission starting on week 24 in Argentina.
Zidovudine (ZDV) pharmacokinetics (PK) during an escalating, multiple-dose study of delavirdine (DLV) mesylate.
Zidovudine (ZDV) pharmacokinetics in AIDS patients receiving granulocyte-monocyte colony stimulating factor (GMCSF).
Zidovudine (ZDV) phosphorylation determined at intervals over 12 months in naive and antiretroviral experienced HIV+ patients.
Zidovudine (ZDV) phosphorylation determined at intervals over 12 months in naive and antiretroviral experienced HIV+ patients.
Zidovudine (ZDV) recovery from phosphorylated anabolites under different experimental conditions using two types of alkaline phosphatase (AP).
Zidovudine (ZDV) susceptibility of HIV strains in 10 asymptomatic patients on long-term ZDV monotherapy.
Zidovudine (ZDV) therapy of HIV infection during pregnancy: assessment of the effect on the newborns.
Zidovudine (ZDV) treatment during pregnancy in an urban population. American Pediatric Association and Society for Pediatric Research annual meeting; 1996 May 6-10; Washington, D.C.
Zidovudine (ZDV) treatment in HIV positive asymptomatic patients (pts.).
Zidovudine (ZDV) treatment in HIV positive asymptomatic patients.
Zidovudine (ZDV) use in children with AIDS before FDA approval.
Zidovudine (ZDV) vs didanosine (DDI) in HIV patients (pts) with less than or equal to 300 CD4 lymphocytes and prior ZDV for greater than 6 months.
Zidovudine (ZDV)-associated myopathy in a large clinic population.
Zidovudine 500 mg/day improves subclinical optic fiber dysfunction in HIV-infection.
Zidovudine 800 mg or zidovudine 500 mg in combination with acyclovir for treatment of HIV-infection.
Zidovudine absorption and diarrhea.
Zidovudine administered every four or every twelve hours.
Zidovudine alone versus zidovudine and acyclovir as treatment for patients with HIV disease.
Zidovudine and combination antiretroviral post exposure prophylaxis.